Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)
March 22 2023 - 8:34AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_________________
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 UNDER
THE SECURITIES EXCHANGE ACT OF 1934
Date: March 22, 2023
UBS Group AG
Commission File Number: 1-36764
UBS AG
Commission File Number: 1-15060
(Registrants' Names)
Bahnhofstrasse 45, Zurich, Switzerland, and
Aeschenvorstadt 1, Basel, Switzerland
(Address of principal executive offices)
Indicate by check mark whether the registrants file or
will file annual reports under cover of
Form 20‑F or Form 40-F.
Form 20-F x Form
40-F o
This
Form 6-K consists of the news release which appear immediately following this
page.
Investor
Relations
Tel. +41-44-234 41 00
Media Relations
Tel. +41-44-234 85 00
22 March 2023
|
News Release
|
Ad hoc announcement pursuant to Article 53 of
the SIX Exchange Regulation Listing Rules
Announcement of tender offer of certain UBS
Group AG senior unsecured bail-in notes
|
|
Zurich, 22
March 2023 – UBS Group AG (the “Issuer”) invites the holders of the EUR 1.5bn
4.625% fixed rate notes due March 2028 with ISIN CH1255915006 and the EUR
1.25bn 4.750% fixed rate notes due March 2032 with ISIN CH1255915014 (together
the “Notes”), both of which were issued on 17 March 2023 (the “Issue Date”), to
tender their Notes for cash (the “Offers").
Whilst UBS has been in compliance with all of its obligations
relating to the Notes since the Issue Date, the Issuer is offering to purchase
the Notes at their respective re-offer price in light of the exceptional
corporate actions announced on 19 March 2023, shortly after the issue date. The
Issuer has decided to launch this exercise as a result of a prudent assessment
of these recent developments and the Issuer's long-term commitment to its
credit investors.
The price payable by the Issuer in respect of the Notes of each
tranche accepted for purchase (the “Purchase Price”) will be (i) in the case of
the Notes due March 2028, 99.932 per cent. of the principal amount of the
relevant Note accepted for purchase, and (ii) in the case of the Notes due
March 2032, 99.518 per cent. of the principal amount of the relevant Note
accepted for purchase.
The Offers commence on 22 March 2023 with the Early Expiration
Deadline on 28 March 2023, and the Final Expiration Deadline on 4 April 2023
(together, the “Expiration Deadlines”), unless extended, withdrawn or
terminated at the sole discretion of the Issuer.
Please refer to the Official Notice published to SIX Swiss
Exchange for more information. The Official Notices are accessible here:
https://www.six-group.com/en/products-services/the-swiss-stock-exchange/market-data/news-tools/official-notices.html#/.
UBS Group AG
Investor
Relations:
Switzerland:
Media
Relations:
|
+41-44-234
41 00
|
Switzerland:
|
+41-44-234
85 00
|
UK:
|
+44-207-567
47 14
|
Americas:
|
+1-212-882
58 58
|
APAC:
|
+852-297-1
82 00
|
UBS
Group AG, News Release, 22 March 2023 Page
1
Investor
Relations
Tel. +41-44-234 41 00
Media Relations
Tel. +41-44-234 85 00
www.ubs.com/media
Disclaimer
This document and the information contained herein are provided
solely for information purposes, and are not to be construed as a solicitation
of an offer to buy or sell any securities or other financial instruments in
Switzerland, the United States or any other jurisdiction. No investment
decision relating to securities of or relating to UBS Group AG, UBS AG or their
affiliates should be made on the basis of this document. UBS undertakes no obligation
to update the information contained herein.
This document contains statements that constitute
“forward-looking statements.” While these forward-looking statements represent
UBS’s judgments and expectations concerning the matters described, a number of
risks, uncertainties and other important factors could cause actual
developments and results to differ materially. For a discussion of the risks
and uncertainties that may affect UBS’s future results please refer to the
“Risk Factors” and other sections of UBS’s most recent Annual Report on Form
20-F, quarterly reports and other information furnished to or filed with the US
Securities and Exchange Commission on Form 6-K. UBS’s Annual Report on Form
20-F, quarterly reports and other information furnished to or filed with the US
Securities and Exchange Commission on Form 6-K are also available at the SEC’s
website: www.sec.gov.
UBS
Group AG, News Release, 22 March 2023 Page
2
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrants
have duly caused this report to be signed on their behalf by the undersigned,
thereunto duly authorized.
UBS
Group AG
By:
_/s/ Kelsang Tsün______________
Name:
Kelsang Tsün
Title:
Managing Director
By: _/s/
Ella Campi_______________
Name: Ella Campi
Title:
Executive Director
UBS
AG
By:
_/s/ Kelsang Tsün______________
Name:
Kelsang Tsün
Title:
Managing Director
By: _/s/ Ella Campi_______________
Name: Ella Campi
Title:
Executive Director
Date: March 22, 2023
UBS (NYSE:UBS)
Historical Stock Chart
From Mar 2024 to Apr 2024
UBS (NYSE:UBS)
Historical Stock Chart
From Apr 2023 to Apr 2024